ABCC2 Antibody

1. The promoter ABCC2 -24C>T SNP affects both triglyceride levels and the TG/HDL-C ratio after short-term low-dose atorvastatin treatment in male but not female hypercholesterolaemic individuals. PMID: 29178257
2. Genetic variability in the ABCC2 gene influences the in vitro expression, trafficking, and transport activity of MRP2. PMID: 28405913
3. Polymorphisms of GSTP1 rs1695 and ABCC2 rs717620 can be used to predict the outcomes of Uygur patients with advanced NSCLC who have received platinum-based chemotherapy. Kaplan-Meier survival analysis indicated that survival with GSTP1 AG+ GG was significantly longer than in patients with AA gene (P<0.05), and survival with ABCC2 CT + TT was significantly longer than in patients with CC gene. PMID: 28442702
4. Results indicate that the response to treatment depends on the variability in genes involved in drug transport, such as ABCC2 c.-24C>T and ABCB1 p.Ser893Ala/Thr, and in DNA repair machinery, such as ERCC2 p.Lys751Gln. PMID: 27527855
5. Self-inhibition of the MRP2-dependent secretion of MTX is a plausible explanation for the time-dependent pharmacokinetic properties of this drug. PMID: 28196047
6. SMS regulates the expression and function of drug transporters P-gp and MRP2. PMID: 27394416
7. Genetic association studies in a population in France revealed that SNPs in ABCC2 are associated with the regulation of secretion of endogenous organic anions. The 3 SNPs investigated (-24C>T, exon 1, rs717620; c.3972C>T, exon 28, rs3740066; c.1249G>A, exon 10, rs2273697) are associated with differential excretion of 35 out of the 108 metabolites analyzed. PMID: 28532626
8. BCRP and MRP2 can mediate the elimination of ochratoxin A from cells, reducing OTA toxicity. PMID: 28532671
9. Four SNPs within the APOE cluster (rs7412, rs4420638), ABCC2 (rs2002042) and CELSR/SORT1/PSRC1 (rs646776) displayed a significant impact on statin efficacy. The weighted genetic risk score (wGRS) was significantly associated with lower LDL-C at age 75 and 80. PMID: 27943270
10. We analyzed 150 SNPs in eight key genes involved in vincristine pharmacokinetics and in 13 miRNAs that regulate them. We studied their correlation with neurotoxicity during the induction phase in 152 ALL patients treated with LAL/SHOP protocols. The strongest associations with neurotoxicity were observed for two SNPs in ABCC2. PMID: 27180762
11. This review focuses on the role of MRP2 in the apical membrane of the enterocytes, as an important component of the intestinal barrier, as well as its regulation. It provides a comprehensive compilation of significant contributions demonstrating that MRP2 expression and function vary under relevant physiological and pathophysiological conditions. PMID: 27109321
12. ABCC2 polymorphisms were associated with hematological toxicity in non-small cell lung cancer patients. PMID: 27590272
13. A meta-analysis indicates that the ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs. PMID: 27816260
14. We investigated the role of ABCB1 rs1045642 and rs2032582 and ABCC2 rs2273697 and rs717620 in antiepileptic drug-resistance. Our study suggests that the ABCC2 rs717620 polymorphism is associated with resistance to antiepileptic drugs in Chinese patients with epilepsy. PMID: 27886333
15. A novel deletion in the ABCC2 gene was identified in families with dual hereditary jaundice. PMID: 26350512
16. Resveratrol-3-O-sulfate was reduced in both MRP2-overexpressing MDCKII-UGT1A1 cells and Human UGT1A9-overexpressing HeLa cells. PMID: 26502886
17. A thalassemia patient was found to be a carrier of UGT1A1 and ABCC2 polymorphisms, explaining a possible reduction of desferasirox metabolism along with a reduction of biliary elimination by MRP2, leading to a serious adverse reaction. PMID: 26403473
18. ABCC2 expression in PBMCs may be influenced by gender, and it's recommended to utilize at least two endogenous control genes in studies. PMID: 26681017
19. Activation of liver PKCs during cholestasis leads to Ezrin Thr567 phosphorylation, resulting in MRP2 internalization and degradation, where ubiquitin ligase E3 GP78 is involved. PMID: 26212029
20. These studies identify Akt2 as a critical kinase that regulates radixin phosphorylation, leading to Mrp-2 translocation and function. PMID: 26500117
21. MRP2 expression in HepG2 cells is repressed by IL-18. PMID: 26292095
22. MRP 2 expression is upregulated by ATP in colorectal cancer cells and enhances their survival to chemotherapeutic drugs. PMID: 26295158
23. There was no association of ABCC2 with the risk of colorectal cancer. PMID: 26109419
24. CYP3A4*22 and ABCC2 haplotypes did not influence tacrolimus trough concentrations. PMID: 26067485
25. ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. PMID: 25890497
26. Data show the influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients. PMID: 25801567
27. This study found that ABCC2 and ABCG2 expression levels were altered already in mild/moderate dysplasia in carcinogenesis. PMID: 25793771
28. Data suggest that hepatic expression of MRP3 is up-regulated and canalicular localization of MRP2 is altered in pediatric patients with advanced nonalcoholic steatohepatitis. These alterations may be involved in changes observed in drug metabolism. PMID: 25788542
29. This study revealed that three polymorphisms, SCN1A IVS5-91G>A, ABCC2 c.1249 G>A and UGT2B7 c.802T>C, are associated with OXC maintenance dose and lnCDR in Han Chinese epilepsy patients. PMID: 25823783
30. The recessive model of G1249A in MRP2/ABCC2 might decrease the risk of drug resistance in Asian epilepsy. PMID: 25847339
31. Data, including data from studies on cloned Caco-2 cells with transporter genes knocked-out, verify that MRP2, MDR1, and BCRP are responsible for the transport of specific xenobiotics (transport of estrone 3-sulfate and nitrofurantoin by MRP2). PMID: 25388687
32. Clinically, no significant association was observed for the ABCC2 genetic variants and CBZ treatment outcomes. This comprehensive analysis does not support a role for ABCC2 in CBZ treatment efficacy. PMID: 24567120
33. Single nucleotide polymorphisms in the ABCC2 gene are associated with acute graft-versus-host disease. PMID: 25425682
34. HIV-infected patients who carry the ABCC2*1C genotype CC at position -24 or have high plasma tenofovir concentration are at risk of decreased glomerular filtration rate. PMID: 24788661
35. Our results suggest that the ABCC2 T -24 G 1249 T 3972 haplotype was associated with imatinib resistance in chronic myeloid leukemia. PMID: 25060527
36. MRP2 was involved in the efflux of herbal preparations, which could be useful for the safe application of these components or their herbs. PMID: 25744397
37. Significant allele association of ABCC2 rs2273697 was observed in Chinese females with epilepsy. PMID: 24624913
38. This study suggested that SCN1A and ABCC2 polymorphisms may be associated with the response to CBZ/OXC in the Chinese Han population. PMID: 25155934
39. There is strong evidence that ABCC2 -24C>T is associated with decreased gene expression. PMID: 25162314
40. NHERF1 is essential for maintaining the localization and function of Mrp-2. PMID: 25163515
41. ABCB1, ABCB4 and ABCC2 polymorphisms do not play a role in enhancing the risk of drug-induced hepatotoxicity in a Spanish cohort. PMID: 24732756
42. This observation may suggest a differential suppression of ABCC2 by miR-379 caused by haplotype-dependent differences in mRNA secondary structures, resulting in changes in mRNA target accessibility or mRNA stability. PMID: 24743544
43. Deficiency in Mrp2 lowers platinum excretion and increases susceptibility to kidney injury, which can be rescued by the human MRP2 ortholog. PMID: 24641901
44. Genotyping for 3972CT and 1249GA ABCC2 gene variants may be useful in acute lymphoblastic leukemia to optimize methotrexate therapy and reduce associated toxicity. PMID: 24552501
45. The ABCC2 G1249A polymorphism is significantly associated with a decreased risk of antiepileptic drug resistance. PMID: 24325761
46. This study provides the first evidence that the -24T allele in the ABCC2 gene is associated with the severity of MTX toxicities. PMID: 24404132
47. Population pharmacokinetics modeling showed that the ABCC2 -24T allele (rs717620) had a combined influence on both MTX elimination and distribution. PMID: 23069858
48. Cholesterol increases the transport rates of ABCB11 and ABCC2, but with the latter, may also modify the binding site as for E17betaG. PMID: 24711118
49. ABCB1, ABCC1, and ABCC2 single nucleotide polymorphisms are associated with the Glasgow Outcome Scale (GOS) score after traumatic brain injury. PMID: 23896815
50. ABCC2 haplotype, as well as CYP3A5 polymorphism, have significant impacts on the pharmacokinetics of tacrolimus. PMID: 23633119

Show More

Hide All

HGNC: 53

OMIM: 237500

KEGG: hsa:1244

STRING: 9606.ENSP00000359478

UniGene: Hs.368243